• Friday
  • October 31, 2014
  • Last updated: 6:49pm
Hong Kong




Refine Your Search

Sort by

Search Results

Results 1 - 10 of 940 for baoshantang pharmaceutical company

Related topics matching your search

Search results

  1. Investors can choose own health risk

    Posted Aug 17th 2003, 12:00am by Jane Parry

    ... will invest in the world's 12 largest pharmaceutical and health-care stocks. The top 10 pharmaceutical companies account for 49 per cent of market share, so this fund gives investors easy access ... cent of sales hold the most interest, and fund manager Caspar Rock says the fund's bias away from big pharmaceutical companies will be to its advantage in the coming year. 'We ...

  2. New Products

    Posted Aug 03rd 2003, 12:00am by Staff Reporter

    ... pharmaceutical and health-care stocks. The fund offers a 100 per cent guarantee and cash dividends totalling 5.75 per cent over the four-year and nine-month investment term. Added bonuses will be based ...

  3. Sino Biopharm exits eye medicine business

    Posted Jul 08th 2005, 12:00am by Staff Reporter

    ... after the sale. Tse Ping said the company would use the proceeds to invest through acquisitions and as working capital for their current pharmaceutical developments. Stephen Tse said the group ... Freda Pharmaceutical and Shandong Chia Tai Freda Packaging Resources. The sale will mark Sino Biopharm's departure from the eye-care medicine business, which accounted for 33 per cent ...

  4. China Pharma aims to increase drug production

    Posted Apr 09th 2009, 12:00am by Staff Reporter

    ... Jasmine Wang China Pharmaceutical Group, a bulk drug manufacturer controlled by mainland private equity firm Legend Holdings, said it aimed to boost production of antibiotic finished drugs ... and growth in profit margin of the vitamin C business. The strong earnings growth and the rise in the final dividend to 20 HK cents from 5 HK cents per share sent the company's shares up as much ...

  5. In Brief

    Posted Mar 17th 2004, 12:00am by Staff Reporter

    ... and how China would respond. Dawnrays earnings rise 7.8pc as turnover soars Dawnrays Pharmaceutical (Holdings) posted a 7.89 per cent gain in net profit to 108.02 million yuan last year. Turnover rose 49.84 per cent to 491.38 million yuan. Basic earnings per share were 15.51 fen, compared with 16.69 fen last year. The company will pay a final dividend of 3.5 fen per share. Massmutual ...

  6. Earnings rise 38pc at state-owned companies

    Posted Jan 18th 2011, 12:00am by Eric Ng

    ... was reportedly studying raising the rate of dividends unlisted state-owned companies must pay and broadening the type of enterprises that have to distribute dividends. ...

  7. Shanghai Industrial earnings rise sharply on HK$3.2b disposal gain

    Posted Aug 31st 2010, 12:00am by Staff Reporter

    ... of a one-off gain from the sale of assets to its parent firm. Net profit surged to HK$4.44 billion from HK$1.4 billion, a 216 per cent increase from a year earlier. The company booked a disposal gain of HK$3.2 billion from the continuing offloading of pharmaceutical assets to its parent company, Shanghai Industrial Investment (Holdings). SIH will pay an interim dividend of 50 HK cents per share. ...

  8. Business - Companies - EARNINGS

    Wheelock looks ahead to strong growth

    Posted Mar 28th 2013, 12:00am by Peggy Sito

    ... property and logistics conglomerate Wheelock and Company expects to see substantial business growth in the next five years. Its project pipeline was unveiled as the company announced a 120 per cent ... Stephen Ng Tin-hoi, the deputy chairman of Wheelock & Co. The dividend payout ratio on the basis of the company's core profit increased to 31 per cent from 11 per cent in 2011, said Ng. ...

  9. Fortune favours the brave

    Posted Nov 28th 2011, 12:00am

    ... 'First, go defensive and never mind the nationality of the stock. Food, pharmaceuticals, utilities and retail. In particular, retail, which is trying to get into the frontier markets of Africa. ... class out there, provided investors do their homework. 'Balance sheets for companies are the best I have ever seen,' Raif says. 'Companies are lean and efficient, ...

  10. CK Life Sciences pays HK$260m for vineyards

    Posted Nov 09th 2010, 12:00am by Charlotte So

    ... Charlotte So CK Life Sciences is to diversify from the development and sale of agricultural-based nutritional and pharmaceutical products into the business of owning vineyards. The Hong Kong-listed bio-technology company announced yesterday it had agreed to buy a majority stake in Australian-listed Challenger Wine Trust for HK$260 million. CWT is a managed investment trust ...




SCMP.com Account